Delivery Order SPE2DB20D1109-SPE2DB22FP61E
Award Date
7/14/22
Potential Completion Date
7/15/22
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,104.08 firm fixed-price contract is for the provision of Moxifloxacin 0.5% eye drops, a specialty pharmaceutical product. The contract has an ultimate completion date of March 12, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is valued at $13,806.60 and covers the delivery of Moxifloxacin 0.5% eye drops, a pharmaceutical product used for medical treatment. The IDC with the DLA Troop Support Medical is a significant single-award contract valued at up to $999,999,999.00, which enables...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4559143810 - Moxifloxacin 0.5% Eye Drops 3ML. The firm fixed-price contract, valued at $1,175.16, has a completion date of November 21, 2022. This contract is not a set-aside and was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Moxifloxacin 0.5% eye drops. The contract, valued at $1,134.00, is a firm fixed-price delivery order that will be completed by July 17, 2024. This order is not associated with a set-aside program. AmerisourceBergen, through its Corporate Office division, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,585.38 firm fixed-price delivery order is for the supply of Moxifloxacin Hydrochloride, a broad-spectrum antibiotic medication. The contract has an ultimate completion date of February 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $50,352.90 firm fixed-price delivery order is for the supply of Moxifloxacin HCL 400 mg tablets to support military healthcare programs. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical division to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $6,514.78 firm fixed price delivery order is for the supply of the pharmaceutical product Moxifloxacin Hydrochloride. The delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company. The $6,195.45 firm fixed price delivery order is for the supply of the pharmaceutical product Moxifloxacin Hydrochloride, with a completion date of October 11, 2023. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $7,346.50 firm fixed price delivery order contract is for the provision of Moxifloxacin Hydrochl, a pharmaceutical product. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical with a potential value of $999,999,999.00 and a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,922.30 Firm Fixed Price delivery order is for the drug Vigamox 0.5% eye drops in 3ml containers, with a completion date of May 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...